Connect with us

Hi, what are you looking for?

Salyersville Independent

Local News

COVID-19 local numbers declining

SALYERSVILLE – Local COVID-19 numbers seem to be on the decline, though another suspected death related to the virus has been reported since last week.

The Magoffin County Health Department confirmed on Wednesday that there were 3 new COVID-19 cases from Magoffin County on Thursday, October 7, 3 on Friday, 8 on Saturday, 0 on Sunday, 6 on Monday, 12 on Tuesday, and 7 as of 3 p.m. on Wednesday, October 13. To date, 2,178 COVID-19 cases have been reported from Magoffin County, with 46 active cases to date (down from 61 on Wednesday last week). Currently, there are four people from Magoffin in the hospital.

Of the 7 new cases on Wednesday, five were under the age of 18 and one case was a breakthrough cases, or of fully-vaccinated individual.

One suspected COVID-19-related death was reported since last week’s paper printed, though it cannot be confirmed until the death certificate comes in.

The Magoffin County Health Department will be giving Moderna vaccines on Tuesday next week and they also have booster Moderna vaccines for the immunocompromised. To qualify for a booster vaccine, people must fall into one of the following categories (from MCHD):

*Been receiving active cancer treatment for tumors or cancers of the blood

*Received an organ transplant and are taking medicine to suppress the immune system

*Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system

*Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)

*Advanced or untreated HIV infection

*Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response

People should talk to their healthcare provider about their medical condition, and whether getting an additional dose is appropriate for them.

Please call, 349-6212 to make your appointment.

Pfizer booster vaccines, available locally at Walgreens, have been approved by the FDA for people over the age of 65 or in jobs where they work with the public six months after they received the second dose.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


You May Also Like

Copyright © 2020 Salyersville Independent. All Rights Reserved.